Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.
Clinical trial NCT00561951 · COMPLETED
Trial details
- NCT number
- NCT00561951
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-01-01
- Enrollment
- 951
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.